» Articles » PMID: 36701435

Structural Basis of Mammalian Respiratory Complex I Inhibition by Medicinal Biguanides

Overview
Journal Science
Specialty Science
Date 2023 Jan 26
PMID 36701435
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular mode of action of biguanides, including the drug metformin, which is widely used in the treatment of diabetes, is incompletely characterized. Here, we define the inhibitory drug-target interaction(s) of a model biguanide with mammalian respiratory complex I by combining cryo-electron microscopy and enzyme kinetics. We interpret these data to explain the selectivity of biguanide binding to different enzyme states. The primary inhibitory site is in an amphipathic region of the quinone-binding channel, and an additional binding site is in a pocket on the intermembrane-space side of the enzyme. An independent local chaotropic interaction, not previously described for any drug, displaces a portion of a key helix in the membrane domain. Our data provide a structural basis for biguanide action and enable the rational design of medicinal biguanides.

Citing Articles

The nuclear pore complex connects energy sensing to transcriptional plasticity in longevity.

Zhou Y, Ahsan F, Soukas A bioRxiv. 2025; .

PMID: 40027662 PMC: 11870510. DOI: 10.1101/2025.02.17.638704.


Reversal of metformin's anti-proliferative effect in fission yeast and (DRP1) mutants with elongated mitochondria.

Gillespie A, Mehdorn A, Lim T, Wang T, Mooney B, Ovens A NPJ Metab Health Dis. 2025; 3(1):5.

PMID: 39991135 PMC: 11845315. DOI: 10.1038/s44324-024-00048-9.


Metformin Induces Apoptosis and Ferroptosis of Ovarian Cancer Cells Under Energy Stress Conditions.

Wu Y, Zhang Z, Ren M, Chen Y, Zhang J, Li J Cells. 2025; 14(3).

PMID: 39937004 PMC: 11817979. DOI: 10.3390/cells14030213.


Chemical imaging unveils mitochondria as the major site of medicinal biguanide accumulation within cells.

Wang L, Zeng X, Li Y, Hao W, Yu Z, Yao L Heliyon. 2025; 10(14):e34595.

PMID: 39816332 PMC: 11734149. DOI: 10.1016/j.heliyon.2024.e34595.


Repurposing of Metabolic Drugs Metformin and Simvastatin as an Emerging Class of Cancer Therapeutics.

Maurya S, Chaudhri S, Kumar S, Gupta S Pharm Res. 2025; 42(1):49-67.

PMID: 39775614 DOI: 10.1007/s11095-024-03811-1.


References
1.
Kampjut D, Sazanov L . The coupling mechanism of mammalian respiratory complex I. Science. 2020; 370(6516). DOI: 10.1126/science.abc4209. View

2.
Batandier C, Guigas B, Detaille D, El-Mir M, Fontaine E, Rigoulet M . The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin. J Bioenerg Biomembr. 2006; 38(1):33-42. DOI: 10.1007/s10863-006-9003-8. View

3.
Schafer G . On the mechanism of action of hypoglycemia-producing biguanides. A reevaluation and a molecular theory. Biochem Pharmacol. 1976; 25(18):2005-14. DOI: 10.1016/0006-2952(76)90423-8. View

4.
Naguib A, Mathew G, Reczek C, Watrud K, Ambrico A, Herzka T . Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells. Cell Rep. 2018; 23(1):58-67. PMC: 6003704. DOI: 10.1016/j.celrep.2018.03.032. View

5.
Hirst J . Mitochondrial complex I. Annu Rev Biochem. 2013; 82:551-75. DOI: 10.1146/annurev-biochem-070511-103700. View